John Slump Launches Metis MedTech After Johnson & Johnson's Acquisition

John Slump Launches Metis MedTech

In an exciting development for the medical technology landscape, John Slump, a well-known figure in the medtech industry, has officially launched Metis MedTech. This initiative comes in the wake of Johnson & Johnson's acquisition of Atraverse Medical, where Slump served as co-founder and former CEO. This strategic move aims to bolster support for medical device entrepreneurs through investment and advisory services.

On May 28, 2026, Slump revealed his vision for Metis MedTech, positioning it as an investment platform dedicated to aiding founders in the medical device sector. With a strong background of success in leading high-value exits for medical device companies, Slump is poised to provide invaluable assistance to those looking to navigate the complex landscape of medical technology.

The acquisition of Atraverse Medical by Johnson & Johnson on May 15 marked a significant moment not only for Slump but also for the broader medtech community. As the landscape shifts, Metis MedTech is set to play a critical role in supporting startups and founders looking to innovate within the industry. Slump emphasizes that the platform's mission is clear: to combine capital investment with hands-on operational support, thereby equipping medical device founders with the tools they need to thrive.

John Slump's impressive track record includes multiple successful exits, totaling over $1.25 billion. Companies like Farapulse, Surgical Innovation Associates, and Attune Medical highlight his capacity for steering medical device innovations from inception to acquisition. At Metis MedTech, founders can expect a partnership that not only provides funding but also practical guidance through critical phases of growth. The platform promises to cultivate an environment where medical device innovators can flourish, armed with both financial resources and operational expertise.

Slump’s perspective on entrepreneur-led ventures highlights an understanding that innovators often possess the deepest insights into their respective markets. He aims to respect and preserve the autonomy of founders while simultaneously offering structured support that fosters rapid execution and sustainable growth. Metis MedTech strives to create a collaborative ecosystem where medical innovations can emerge quickly and efficiently, addressing pressing clinical needs in a timely manner.

Metis MedTech is already making strides with its inaugural investments and advisory efforts. Among recent collaborations are companies like Field Medical and StimCardio Medical, where Slump has actively led financing rounds. His commitment to fostering a founder-friendly investment landscape is evident as he identifies and partners with emerging medical technology leaders.

Dr. Steven Mickelsen, co-founder of Atraverse Medical and CTO of Field Medical, has praised Slump as an archetypal entrepreneur, emphasizing his capacity for building and scaling medtech companies. This endorsement underscores the supportive culture Metis MedTech aims to create, enabling innovators to launch transformative medical technologies in cardiovascular, neurovascular, and other high-impact markets.

In conclusion, with Metis MedTech, John Slump is set to ignite a new wave of innovation within the medical device sector. By blending investment with strategic advisory services, he is empowering founders to push boundaries and create solutions that meet critical medical needs. Slump’s commitment to preserving founder control while providing operational backing could prove to be a game-changer in the medtech landscape. Founders seeking to explore opportunities with Metis MedTech are encouraged to reach out to the platform for alignment in their journey toward success.